Gem Aromatics Ltd

As of March 2025, Gem Aromatics reported net sales of 503.95 crore, an operating profit margin of 17.55%, and a profit after tax margin of 10.59%. The company experienced balanced growth in total assets and liabilities, with a negative cash flow from operations of -24.00 crore and earnings per share of 11.39.

As of October 14, 2025, Gem Aromatics is considered an attractive investment due to its undervaluation indicated by a PE ratio of 22.85, an EV to EBITDA of 15.39, and a ROCE of 19.07%, despite a recent stock decline of 19.48% over the past month.

As of October 9, 2025, Gem Aromatics is fairly valued with a PE ratio of 24.46, an EV to EBITDA of 16.36, and a ROCE of 19.07%, making it less expensive than peers like Solar Industries and Gujarat Fluoroch, despite a recent stock performance lag compared to the Sensex.

As of October 8, 2025, Gem Aromatics is considered undervalued with a PE ratio of 23.39 and strong financial metrics, despite a recent stock decline of -20.33%, making it an attractive investment compared to its expensive peers.

As of October 1, 2025, Gem Aromatics is considered fairly valued with a PE ratio of 25.17 and an EV to EBITDA ratio of 16.79, especially when compared to more expensive peers like Solar Industries and Gujarat Fluoroch, despite underperforming against the Sensex recently.

As of October 1, 2025, Gem Aromatics is fairly valued with a PE ratio of 25.17 and lower valuation metrics than its expensive peers, despite lagging behind the Sensex with a recent return of -6.51%.

As of September 26, 2025, Gem Aromatics is considered undervalued with a PE ratio of 23.55 and a PEG ratio of 0.00, indicating attractive growth potential compared to its peers, despite a recent stock decline of 11.57%.

As of September 26, 2025, Gem Aromatics is considered undervalued with a PE ratio of 23.55 and a PEG ratio of 0.00, despite a recent stock decline, positioning it attractively compared to more expensive peers like Solar Industries and Gujarat Fluoroch.

As of September 26, 2025, Gem Aromatics is considered an attractive investment due to its undervalued key ratios, including a PE ratio of 23.55 and a PEG ratio of 0.00, despite a recent stock decline of 11.57%.

Gem Aromatics, a small-cap specialty chemicals company, has faced a challenging market since its IPO in August 2025, currently trading significantly below its issue price. Despite a slight outperformance against its sector, the stock remains near its 52-week low, with declining investor participation and lower delivery volumes.

Gem Aromatics, a small-cap specialty chemicals company, has seen a decline in stock performance, trading below key moving averages. Investor interest has decreased significantly, with a notable drop in delivery volume. Compared to peers, the company is viewed as fairly valued, facing challenges in a competitive market.

Gem Aromatics, a small-cap specialty chemicals company, has faced challenges since its IPO in August 2025, with a significant decline in stock performance. The company is currently trading below key moving averages, experiencing reduced investor participation, and is considered less competitive compared to peers in the sector.

As of September 16, 2025, Gem Aromatics is fairly valued with a PE ratio of 27.53 and an EV to EBITDA of 18.21, positioning it competitively in the specialty chemicals sector despite a recent 1-week stock return of -6.73%.

Gem Aromatics has shown increased trading activity on September 16, 2025, following a three-day decline. The stock reached an intraday high, with notable investor participation reflected in rising delivery volumes. However, it continues to trade below key moving averages and does not compare favorably to its peers in valuation metrics.

Gem Aromatics, a small-cap specialty chemicals company, has faced notable volatility since its IPO, with a significant decline in stock performance and underperformance compared to its sector. The stock is trading below key moving averages, and investor participation has decreased, reflecting challenges in a competitive market.

Gem Aromatics has shown significant growth in its consolidated balance sheet, with shareholder's funds increasing from 138.16 Cr in Mar'22 to 283.98 Cr in Mar'25, and total reserves rising from 136.37 Cr to 274.61 Cr. However, cash flow from operating activities turned negative in Mar'25, despite profit before tax improving from 44.00 Cr to 74.00 Cr.

Gem Aromatics, a small-cap specialty chemicals company, has faced a decline since its IPO, underperforming its sector. Despite recent challenges, the stock remains above key moving averages and has seen increased investor participation. However, it lacks a defined quality rating compared to peers and has a relatively high price-to-earnings ratio.

Gem Aromatics, a small-cap specialty chemicals company, has experienced significant activity recently, with a notable intraday high and strong short-term momentum. However, investor participation has declined, and the company lacks a defined quality rating compared to its peers, highlighting its unique position in the sector.

Gem Aromatics will declare its results on 12 September 2025.